Bryan, Garnier & Co

Over the past 27 years, Bryan, Garnier & Co has solidified its position as the leading independent, growth-focused, full-service investment bank in Europe. 💼 In 2024, the firm completed more than 60 transactions in the European technology and healthcare sectors and recorded a 20% increase in deal volume despite challenging market conditions.   🤝 The merger with Stifel redefines cross-continental, growth-focused investment banking, marking the beginning of a new phase of development for Bryan, Garnier & Co and Stifel in Europe, united as "One Stifel." 🏆 Stifel is the #1 US mid-market M&A advisor and ECM bookrunner since 2012.   Olivier Garnier, Founder and Managing Partner at Bryan Garnier said: “This strategic combination, which brings together Bryan Garnier's leading European franchise with the strengths of a North American mid-market powerhouse, marks a new phase in our journey to establish the premier growth-focused investment bank in Europe.”   Greg Revenu, Co-founder and Managing Partner at Bryan Garnier added, “By integrating our expertise and resources across M&A advisory, growth financing, equity and debt solutions across private and public markets, we are offering unparalleled opportunities for clients, employees, and the broader European market.”   🌍 Operating under the Stifel brand, the combined firm will benefit from a unified global leadership team to drive innovation, foster growth, and shape the future of the industry.   #InvestmentBanking #MergersAndAcquisitions #Technology #Healthcare #Growth #Innovation #BryanGarnier #Stifel

📈 Who’s on track to join Europe’s billion-dollar startup elite? https://lnkd.in/d-9fYcYb 🌍 Tech Tour has just revealed its 2025 Growth50 List, spotlighting 50 of Europe’s most promising companies in digital, health, and sustainability. 💡This year's list highlights the growing importance of deep tech, with a particular focus on quantum computing, AI for health, photonics, biotech, and green energy among others. 🏆 To celebrate these growth companies, three prestigious awards will be given to companies that stand out for their exceptional achievements. 📅 Bryan Garnier is excited to support ambitious companies by partnering with Tech Tour for the 2025 edition of the Tech Tour Growth50 Europe Summit, happening in Paris on March 4th. To learn more about the event and explore the full list of Growth50 companies, visit: https://lnkd.in/epbhucYZ Aleph Alpha, D-Orbit, Isar Aerospace, Paragraf, Scality France, ANYbotics, EFFECT Photonics, Lakera, Pasqal, SMART Photonics, Axelera AI, FINN, Multiverse Computing, Quantum Motion, The Exploration Company, Dispelix, GitGuardian, Nearfield Instruments , Robovision, Wirepas, AQEMIA, Diabeloop, INBRAIN Neuroelectronics, Microsure, UroMems, Carthera, Distalmotion, InnovHeart, ONWARD Medical, CorWave, Immatics, MMI - Medical Microinstruments, Inc., Tubulis GmbH, Wandercraft #BryanGarnier #TechTour #Growth50 #Innovation #DeepTech #Sustainability #HealthTech #Biotech #GreenEnergy #ClimateTech #Startups #Leadership

🥖 The Bakery Sector: A Rising Star in M&A for 2025 The bakery industry is serving up a recipe for robust M&A activity this year. From better-for-you niches like sugar-free, high-protein, and allergen-friendly products to staples like fresh bread and indulgent treats, opportunities abound for investors and food manufacturers alike.   Why is bakery hot right now? 🌍 Fragmented market: The sector is ripe for further consolidation, with regional innovators as well as sub-scale players drawing attention from global players and private equity. 🥗 Health-focused innovation: Consumer demand for cleaner, healthier options is fueling growth in specialty baked goods. 🍰 Indulgence with a twist: Traditional fresh or frozen pastries and cakes remain attractive, particularly as companies innovate to meet changing tastes.   Players like Mondelēz International, Grupo Bimbo, Flowers Foods & Subsidiaries and financial sponsors are targeting strategic acquisitions to achieve scale, boost innovation, compete with private-label challengers and put together new platforms.   As Andreas Kulcsar, Managing Director at Bryan Garnier’s NextGen Team, notes: 2024 was a strong year for bakery M&A, and the momentum continues into 2025. At Bryan Garnier, we are committed to helping growth companies in the bakery sector capitalize on transformative M&A opportunities in 2025.   #Bakery #MergersandAcquisitions #Innovation #FoodIndustry #BetterForYou #BryanGarnier

📢 Mark Your Calendars!  Bryan Garnier & Co, in partnership with POELLATH, is hosting an exclusive evening in Munich: Are Secondaries Reshaping the Future of Venture Capital? 📅 When: Thursday, 20th February 2025  📍 Where: Munich Discover how the secondaries market is transforming venture capital and growth equity and register your interest today. Sign up here: https://lnkd.in/d3zPgyNU 📥 Spaces are limited and by invitation only. We look forward to welcoming you to this unmissable event! #VentureCapital #GrowthEquity #Secondaries #Networking #BryanGarnierEvents

🚗 5 reasons to be super optimistic about the European mobility sector in 2025. 📉 Over the last couple of years, the mood within the broader mobility ecosystem has undoubtedly hit rock bottom. 🚀 The good news? The past negative sentiment is progressively vanishing driven by many European businesses achieving successful milestones. Zag Daily caught up with Florent Roulet, Partner and Head of Mobility at Bryan Garnier, to discuss 2025 prospects and the shift from "survival mode" to "profitable growth mode”. Read more: https://lnkd.in/dP36gDuX #Mobility2025 #EuropeanMobility #Growth #FutureOfMobility #SustainableTransport

🌍 How are smart grids shaping the future of energy? Join us in this episode of Bryan Garnier's Insights Series, where we focus on Aidon, a leader in smart metering solutions, with exclusive insights from Tommi Blomberg, CEO of Aidon, and Henrik Flygar, Partner at Alder. Read more: https://lnkd.in/dEVZ-BFK Aidon is driving the smart grid revolution, delivering advanced solutions that help utilities adapt to the challenges of a rapidly evolving energy landscape. In this episode, we explore: 🌱 The pivotal role of smart grids in enabling the shift to sustainable energy 💡 The increasing demand for resilient and efficient grids in the era of decarbonisation 🚀 How Aidon’s partnership with Gridspertise is accelerating global expansion opportunities As the energy sector transforms, smart grids are becoming a cornerstone of innovation, sustainability, and growth, thanks to companies like Aidon. ⚡At Bryan Garnier, we are proud to support innovators building a brighter, more sustainable energy future. Tor Berthelius, Falk Mueller-Veerse, Jay Marathe, Viktor Östman, Philip Kristoffersson #EnergyInnovation #SmartGrids #Sustainability #Decarbonisation #EnergyTransition 

🌐 Bryan, Garnier & Co acts as Sole Financial Advisor to Collaboration Factory AG (cplace), a leading provider of collaborative software solutions for complex project management, on its sale to Level Equity. More about the deal: https://lnkd.in/dzShAxSd 📈 Collaboration Factory AG (cplace) is a software company recognised as a leader in project and portfolio management (PPM) solutions. Level Equity’s strategic guidance and value-added resources could help cplace enhance its go-to-market strategy, accelerate innovation, and strengthen its leadership in project and portfolio management solutions. 🌍 This marks another landmark transaction for Bryan, Garnier & Co’s software practice, showcasing its expertise in private equity-led transactions in Europe. Other notable software transactions include the investment of Hg in smartTrade Technologies, the MBO of Horizon Software led by CAPZA, the sale of Sword Group GRC to TA Associates, and the investment of Five Arrows Growth Capital in padoa. More about the deal: https://lnkd.in/dzShAxSd Falk Mueller-Veerse, Berk Kirca, Martin Eichler, Hakan Atmali, Diyar Masyan #PPM #SPPM #APM #cplace #Software #CitizenDevelopment #Software

📊 Did you know? The orthobiologics market is highly diversified, with no pure-play company holding more than 10% market share. Maria Vara, Healthcare Analyst at Bryan Garnier, highlights key trends and strategic moves shaping the orthobiologics market in a recent interview with Dagens industry https://lnkd.in/d56Di-Ap 📈 BONESUPPORT AB: A Standout in Orthobiologics The company's impressive +100% LTM performance highlights how its antibiotic-eluting CERAMENT is transforming the practices of US orthopaedic surgeons. 🔬 Expanding into the Spine Market Building on strong demand in the US orthobiologics extremity market, BoneSupport is preparing to launch products for spine fusion indications, with minimal regulatory hurdles. 📱 A Fragmented, Yet Active Market As regenerative treatments mature, we anticipate increasing consolidation, making these companies attractive acquisition targets for larger orthopaedic firms. 🔮 Looking Ahead to 2025 The orthobiologics segment is poised for continued growth, with 2025 expected to offer significant opportunities as the market remains one of the most dynamic since 2020. #Orthobiologics #HealthcareInnovation #OrthopaedicMarket #RegenerativeMedicine #BoneSupport

In 2024, we proudly supported founders, family businesses, entrepreneurs, and their investors in achieving remarkable milestones. 📉 Despite market challenges, we left no stone unturned, delivering innovative solutions to drive growth for ambitious European companies. 🎥 Watch the video below to celebrate our clients' incredible achievements and Bryan Garnier's standout moments from 2024. 🎊 Wishing all our clients, business partners, and friends a Happy New Year from the entire Bryan Garnier team! #HappyNewYear #Innovation #Growth #MergersAndAcquisitions #GrowthCapital

🌟 As we close out 2024, we would like to thank our clients for trusting Bryan Garnier & Co and our public capital markets expertise throughout the year. 💡 From advancing sustainable shifts in Energy Transition, to developing innovative solutions in Tech, as well as pioneering breakthrough therapies and medical technologies, we've had the privilege of working alongside visionary founders and revolutionary businesses to accelerate growth and foster meaningful change. 🏆 Here’s a look at some of our standout Public Equity Capital Markets transactions this year and how we've contributed to shaping success stories in 2024. 👏 A special thanks to Pierre Kiecolt-Wahl, Christophe Alleman, Jerome Guyot, Jean de Pracomtal, Paul Lequeux, Theodore de Charsonville, Pierre-Etienne Bénaich, Camille Dubroc, and Hugo Fischer for turning visionary ambitions into reality. #SustainableGrowth #LifeSciences #Innovation #PublicEquity #BryanGarnier #YearInReview